Bioventix PLC (LON:BVXP - Get Free Report) insider Bruce Hiscock purchased 61 shares of the business's stock in a transaction on Monday, December 23rd. The shares were bought at an average cost of GBX 273 ($3.42) per share, with a total value of £166.53 ($208.76).
Bruce Hiscock also recently made the following trade(s):
- On Friday, November 22nd, Bruce Hiscock acquired 24 shares of Bioventix stock. The shares were bought at an average cost of GBX 3,822 ($47.91) per share, for a total transaction of £917.28 ($1,149.91).
- On Wednesday, October 30th, Bruce Hiscock bought 300 shares of Bioventix stock. The stock was purchased at an average cost of GBX 3,330 ($41.75) per share, with a total value of £9,990 ($12,523.51).
Bioventix Price Performance
Shares of LON:BVXP opened at GBX 3,174.76 ($39.80) on Wednesday. The firm's 50 day simple moving average is GBX 3,634.44 and its two-hundred day simple moving average is GBX 3,989.98. The company has a market capitalization of £165.72 million, a P/E ratio of 1,947.70 and a beta of 0.35. Bioventix PLC has a 1-year low of GBX 2,977 ($37.32) and a 1-year high of GBX 5,100 ($63.93).
Bioventix Increases Dividend
The company also recently announced a dividend, which was paid on Thursday, November 21st. Investors of record on Thursday, November 7th were paid a dividend of GBX 87 ($1.09) per share. This is a boost from Bioventix's previous dividend of $68.00. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 2.4%. Bioventix's payout ratio is 9,693.25%.
About Bioventix
(
Get Free Report)
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits | Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
